A team approach is necessary to provide comprehensive care in today’s complex healthcare settings. And nowhere is the need for a cadre of medical professionals more evident than within the practice of rheumatology, where complicated diagnoses and tailored treatments are the rule rather than the exception. Among the highly trained members of these healthcare teams…
RheumMadness is an online tournament in which a bracket of teams, representing key learning concepts in rheumatology, compete against each other in a series of head-to-head matchups, much like basketball teams in the NCAA’s March Madness. The 2023 tournament theme was The All Star Season. Each team represented one all star article competing to be…
Stepping into the role of ACR secretary, William F. Harvey, MD, MSc, FACR, will pursue member engagement and corporate relations priorities, building on his long history of volunteer work in the College.
A Roshi (i.e., master) apparently said that in Zen, “there is nothing to believe and everything to discover.” Interestingly enough, I have never been able to confirm who actually said that, which makes this saying about belief and discovery particularly apt. Regardless, I think about those words at least twice a day when I am…
Rheumatologists living in Ukraine press on with their work of treating patients despite the ongoing war that began with a Russian military invasion.
Dr. Rodanthi Kitridou is fondly remembered by a mentee as a trailblazer and role model.
A tribute to the life and distinguished career of Naomi Rothfield, MD, MACR.
A new white paper and position statement from the ACR address the clinical and economic value of rheumatology, including patient outcomes and healthcare cost savings.
See key changes for the Merit-Based Incentive Payment System for the 2024 performance year as outlined in the proposed rule.
Your patient with rheumatoid arthritis (RA) isn’t responding well enough to methotrexate, and you both agree it’s time to consider a biologic or targeted synthetic disease-modifying anti-rheumatic drug (DMARD). But which one should you choose? In a treat-to-target era, we’re fortunate to have a variety of RA therapies at our disposal. Clinical practice guidelines from…